Short communication: kidney dysfunction among HIV-infected children in Latin America and the Caribbean

Cristina B Hofer1, D Robert Harris, Ricardo Hugo de Oliveira

  • 11 Department of Preventive Medicine, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil .

Insights

Kidney dysfunction was rare in children with HIV receiving antiretroviral therapy. This study found low prevalence and incidence rates, indicating a good safety profile for these treatments in pediatric patients.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • Antiretroviral therapy (ART) is crucial for managing HIV infection in children.
  • Potential renal toxicity associated with ART necessitates ongoing safety monitoring.
  • Understanding kidney health in perinatally HIV-infected children is vital for long-term care.

Purpose of the Study:

  • To determine the prevalence and incidence of kidney dysfunction in perinatally HIV-infected children in Latin America and the Caribbean.
  • To assess the renal safety of antiretroviral medications in this pediatric population.

Main Methods:

  • A multicenter cohort study design was employed.
  • Data were collected from 1,032 perinatally HIV-infected children between 2002 and 2011.
  • Kidney dysfunction was defined and monitored throughout the follow-up period.

Main Results:

  • The prevalence of kidney dysfunction was low at 1.7% (95% CI: 1.0-2.6%).
  • The incidence rate of kidney dysfunction was 0.17 cases per 100 person-years (95% CI: 0.04-0.30).
  • These findings suggest a rare occurrence of kidney dysfunction in this cohort.

Conclusions:

  • Renal toxicity appears to be a rare complication in perinatally HIV-infected children receiving ART in Latin America and the Caribbean.
  • The study supports the generally favorable renal safety profile of antiretroviral treatments in this vulnerable pediatric population.
  • Continued surveillance is important to confirm these findings in diverse populations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
826
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.7K